AlphaFold predicted structure
TXNRD1 · Q16881
Mean pLDDT
Not published
AlphaFold has not published a prediction for this sequence. This is common for very long proteins.
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0
thioredoxin reductase 1
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Early onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalacute promyelocytic leukemia
neoplasm
brain cancer
acute myeloid leukemia
diphtheria
Arthritis
rheumatic disorder
myelodysplastic syndrome
non-small cell lung carcinoma
schizophrenia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Thioredoxin reductase 1, cytoplasmic
Reduces disulfide protein thioredoxin (Trx) to its dithiol-containing form (PubMed:8577704). Homodimeric flavoprotein involved in the regulation of cellular redox reactions, growth and differentiation. A selenocysteine residue at the C-terminal active site is essential for catalysis (Probable). Also has reductase activity on hydrogen peroxide (H2O2) (PubMed:10849437)
TXNRD1 · Q16881
Mean pLDDT
Not published
AlphaFold has not published a prediction for this sequence. This is common for very long proteins.
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0